Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tzipi Lustig"'
Autor:
Osnat Bohana-Kashtan, Margaret M. Showel, Martin S. Tallman, Jessica K. Altman, Abi Vainstein-Haras, James M. Foran, Avichai Shimoni, Arnon Aharon, Michal Abraham, Yaron Pereg, Shaul Kadosh, Arnon Nagler, Ella Sorani, Yishai Ofran, Galia Oberkovitz, Naveen Pemmaraju, Amnon Peled, Ahmed AlRawi, Emil Samara, Geoffrey L. Uy, Tzipi Lustig, Michael Andreeff, Irit Glicko-Kabir, Stephen Shaw, Jorge E. Cortes, Carlos E. Bueso-Ramos, Adam Foley-Comer, Gautam Borthakur, John F. DiPersio, Jacob M. Rowe
Publikováno v:
CancerReferences. 127(8)
Background CXCR4 mediates the retention and survival of acute myelogenous leukemia blasts in bone marrow and contributes to their resistance to chemotherapy. The authors evaluated a combination of the high-affinity CXCR4 antagonist BL-8040 with high-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361f91de0dbad69405fb83eb9466f1d7
https://pubmed.ncbi.nlm.nih.gov/33270904
https://pubmed.ncbi.nlm.nih.gov/33270904
Autor:
Rui-Yu Wang, Yishai Ofran, Martin S. Tallman, Arnon Aharon, Michael Andreeff, Yaron Pereg, Jessica K. Altman, John F. DiPersio, Tzipi Lustig, Abi Vainstein, Amnon Peled, Ahmed AlRawi, Arnon Nagler, Geoffrey L. Uy, Jorge E. Cortes, Galia Oberkovitz, Carlos E. Bueso-Ramos, Gautam Borthakur, James M. Foran, Michal Abraham, Jacob M. Rowe, Margaret M. Showel
Publikováno v:
Blood. 128:2745-2745
Background: Persistence of minimal residual disease (MRD) after induction, consolidation and salvage therapies is an independent poor prognostic marker in AML. The bone marrow (BM) microenvironment is a protective niche that promotes chemotherapy res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2065eb9d091ab40cc20c796e842dfde6
https://doi.org/10.1182/blood.v128.22.2745.2745
https://doi.org/10.1182/blood.v128.22.2745.2745
Autor:
Galia Oberkovitz, Carlos E. Bueso-Ramos, Michal Abraham, Michael Andreeff, Jacob M. Rowe, Abi Vainstein, Yaron Pereg, Jessica K. Altman, Jorge E. Cortes, Arnon Nagler, Yishai Ofran, John F. DiPersio, Geoffrey L. Uy, Martin S. Tallman, Margaret M. Showel, Arnon Aharon, James M. Foran, Gautam Borthakur, Amnon Peled, Tzipi Lustig
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::802237d81be80956977e9020186317a1
https://doi.org/10.1016/j.clml.2016.07.040
https://doi.org/10.1016/j.clml.2016.07.040